Significant service restrictions in the lending area from 17 March!

Result: Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity

Title:
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity : the CERTAIN double-blind, randomised, placebo-controlled trial / J. S. Smolen ; P. Emery ; G. F. Ferraccioli ; W. Samborski ; F. Berenbaum ; O. R. Davies ; W. Koetse ; O. Purcaru ; B. Bennett ; H. Burkhardt
Involved:
Smolen, Josef S. ; Emery, Paul; Ferraccioli, Gianfranco; Samborski, Wlodzimierz; Berenbaum, Francis ; Davies, Owen R.; Koetse, Willem; Purcaru, Oana; Bennett, Barbara; Burkhardt, Harald 
Published in:
Annals of the rheumatic diseases. - [Amsterdam] : Elsevier, 1939-. - ISSN 1468-2060. - Band 2014, Heft 0 (2014)
Show all articles
Manufacturing:
2014
Scope:
Online-Ressource
Format:
e-article
Language:
English
DOI:
10.1136/annrheumdis-2013-204632

Additional information

Additional functions